Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.

Expert opinion on drug metabolism & toxicology - 1 Jan 2011

Gentile Giovanna, Borro Marina, Simmaco Maurizio, Missori Serena, Lala Noemi, Martelletti Paolo

Abstract excerpt

IMPORTANCE OF THE FIELD: Migraine is a debilitating and painful neurological disorder affecting millions of people worldwide and often worsened by chronification. Triptans represent a powerful pharmacological resource in migraine management; nevertheless, a significant portion of treated patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Genetic Association Studies
Share to Genome, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Migraine Disorders

Share to Monoamine Oxidase

Share to Pharmacogenetics

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 21142809
DOI: 10.1517/17425255.2011.538680

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21142809-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.PMID 21142809Read ↗

Pathways to the best fit of triptans for migraine patients.Semantic proximity Read ↗

Molecular mechanisms of migraine: prospects for pharmacogenomics.Semantic proximity Read ↗

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.Semantic proximity Read ↗

Clinical and genetic characterization of non-optimal triptan response among migraine patients.Semantic proximity Read ↗

The impact of genetic factors on the response to migraine therapy.Semantic proximity Read ↗

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.Semantic proximity Read ↗

Genetic and Phenotypic Profiling of Triptan Users in a Swedish Cluster Headache Cohort.Semantic proximity Read ↗

The influence of genetic constitution on migraine drug responses.Semantic proximity Read ↗

Pharmacogenomics and migraine: possible implications.Semantic proximity Read ↗

Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.Semantic proximity Read ↗

5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.Semantic proximity Read ↗

Pharmacogenetics in Primary Headache DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.